a public good project by the
Synthesis
Company
of California

© 2026

Andrea Pellagatti | doi.page

0 works0 citations0 h-index

Andrea Pellagatti

John Radcliffe Hospital(GB)University of Oxford(GB)

Publications by Year

Research Areas

Acute Myeloid Leukemia Research, Myeloproliferative Neoplasms: Diagnosis and Treatment, RNA Research and Splicing, Chronic Myeloid Leukemia Treatments, RNA modifications and cancer

Most-Cited Works

→ Clinical and biological implications of driver mutations in myelodysplastic syndromes(2013)1,816 cited
→ SomaticSF3B1Mutation in Myelodysplasia with Ring Sideroblasts(2011)1,210 cited
→ Molecular International Prognostic Scoring System for Myelodysplastic Syndromes(2022)765 cited
→ Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes(2020)618 cited
→ Myelodysplastic Syndromes Are Propagated by Rare and Distinct Human Cancer Stem Cells In Vivo(2014)319 cited
→ SF3B1-mutant MDS as a distinct disease subtype: a proposal from the International Working Group for the Prognosis of MDS(2020)289 cited

→ Deregulated gene expression pathways in myelodysplastic syndrome hematopoietic stem cells(2010)

286 cited

→ Frequent mutation of the polycomb-associated gene ASXL1 in the myelodysplastic syndromes and in acute myeloid leukemia(2010)259 cited

→ TP53 mutation status divides myelodysplastic syndromes with complex karyotypes into distinct prognostic subgroups(2019)252 cited

→ Combining gene mutation with gene expression data improves outcome prediction in myelodysplastic syndromes(2015)252 cited